-
Pathfinder Members' Briefing and Q&A - March 2023
23 March 2023
Zoom recording of our Pathfinder members' briefing and Q&A for March 2023
-
Pathfinder Members' Briefing and Q&A - March 2023
23 March 2023
Zoom recording of our Pathfinder members' briefing and Q&A for March 2023
-
Rob Verkerk to lead ANH both sides of the Atlantic
13 April 2023
With challenges to natural health and freedom mounting in the USA, the UK and Europe, ANH USA and International teams consolidate, with Verkerk as leader
-
Learn & Journey: ANH events (week 47/2022)
23 November 2022
Upcoming events, conferences and available courses
-
Pathfinder Members' Briefing and Q&A - April 2023
20 April 2023
Zoom recording of our Pathfinder members' briefing and Q&A for April 2023
-
Pathfinder Members' Briefing and Q&A - April 2023
20 April 2023
Zoom recording of our Pathfinder members' briefing and Q&A for April 2023
-
Learn & Journey: ANH events (week 45/2022)
09 November 2022
Upcoming events, conferences and available courses
-
Are you up for taking Big Pharma's new 'skinny' jab?
16 March 2023
After a succession of Big Pharma failures for anti-obesity drugs, will Novo Nordisk's latest offering, that emerges from something of a dark cloud, be just another side effect ladened sticking plaster, or a boon for users and a cash cow for its manufacturer?
-
Learn & Journey: ANH events (week 44/2022)
02 November 2022
Upcoming events, conferences and available courses
-
Learn & Journey: ANH events (week 49/2022)
07 December 2022
Upcoming events, conferences and available courses